Cronos Group Inc. Common Share (CRON)
CRON trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.20
-0.31% on the day
Market cap
$1.2B
Small cap
Revenue · 2025
$146.6M
+24.6% on 2024
Net income · 2025
-$2.9M
-2.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CRON on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001656472 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | A1 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $146.6M |
| Net income | -$2.9M |
| Operating income | -$17.4M |
| Net margin | -2.0% |
| Operating margin | -11.9% |
| Revenue growth | +24.6% |
| Cash | $791.8M |
| Total assets | $1.2B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 8.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-09-11 |
| Latest proxy | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 496 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.5% |
| 1 month | -0.3% |
| 3 months | +16.0% |
| Year to date | +21.3% |
| 1 year | +25.1% |
| From 52-week high | -10.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TRLV | Trulieve Cannabis Corp. Subordinate Voting Shares | $10.11 | -2.69% | $1.9B |
| RLX | RLX Technology Inc. | $1.71 | -0.58% | $2.1B |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
| OBIO | Orchestra BioMed Holdings Inc. | $5.72 | -3.21% | $343.8M |
| RGC | Regencell Bioscience Holdings Limited | $8.19 | +14.87% | $4.1B |
| GLAS | Glass House Brands Inc. Subordinate Voting Shares | $3.85 | -5.64% | $338.8M |
| CGC | Canopy Growth Corporation Common Shares | $0.7625 | +0.66% | $322.6M |
| DFTX | Definium Therapeutics Inc. Common Shares | $34.38 | -2.33% | $4.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier